Breast cancer is the most common cancer in
women and the second leading cause of cancer
deaths. The risk of breast cancer increases with age. About 77% of women with
breast cancer are older than age 50 at diagnosis. Persons at high risk include
those who carry or develop certain genetic mutations and those with a family
history of breast
cancer.
Studying about breast cancer nursing will
provide us with the principles of breast cancer nursing in order to improve our
knowledge and skills for the provision and coordination of evidenced based
breast cancer care. Some women, whether due to family history, genetic
tendencies, and/or other factors, can be considered high risk for cancer
development and should be screened with MRIs as early as age 30. Though this is
said to be a small number of patients, guidelines also state that those women
who do undergo MRI screening should do so in addition to a mammogram
because an MRI could miss some cancers that a mammogram would detect even
though they are more likely to detect cancer than a mammogram.
U.S. Food and Drug Administration also
expanded the approved use of Lynparza to include the treatment of patients
living with certain types
of breast cancer that have spread and whose tumors have a specific
inherited genetic mutation, making it the first drug in its class (poly ADP
ribose polymerase inhibitor) approved to treat breast cancer.
For more details about Breast Cancer Congress
2020 conference:
Please follow the link: https://frontiersmeetings.com/conferences/breastcancercongress/
For queries and details contact us: breastcancer@frontierscongress.com
No comments:
Post a Comment